The IMPACT consortium comprises four UK Universities and four partner organizations from Bangladesh, India and Pakistan. Coordinated by the University of York, IMPACT’s UK partners include the London School of Economics and Political Science, UK, University of Keele, UK, University of Dundee, UK, University of York/ Hull York Medical School, UK. Our South Asian partners include Rawalpindi Medical University, Pakistan, Institute of Psychiatry, RMU, Pakistan, ARK Foundation, Bangladesh, National Institute of Mental Health, Bangladesh, National Institute of Mental Health and Neuroscience (NIMHANS), India. The study is financially supported by Medical Research Council (MRC-UKRI). We are supported by key stakeholders, including the World Health Organization (WHO). The governance, activities and progress of IMPACT are overseen by an International Advisory Board (IAB), comprising members from the George Washington University, USA, Kings College London, Duke NUS Graduate Medical School, Singapore, Coventry and Warwickshire Partnership
General Objectives: Investigate impact of the pandemic and its response on people with SMI and on mental health care in Bangladesh.
Specific Objectives:
- Explore receipt and response of SMI patients to advice about preventing spread of Covid-19
- Understand pandemic’s impact on SMI patient’s well-being, health, health risk behaviours, quality of life; access to/receipt of mental & physical healthcare; housing and food security, domestic violence, employment and income
- Explore impacts on mental health care
- Inform strategies to mitigate the impact of the pandemic on people with SMI and healthcare services.